An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)
NCT01392729
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Cell Cancer
Sponsor
Hoffmann-La Roche